Clinical Trials Browser

INDUSTRY × tazemetostat × 30 days × Clear all

NCT04179864 2026-03-10

CELLO-1

Phase 1/2 Terminated

102 enrolled 39 charts

Prostatic Neoplasms

NCT04224493 2026-03-02

SYMPHONY-1

Phase 3 Recruiting

Lymphoma, Follicular